NWL
53
3
HPQ
63
6
KEY
46
3
VNO
60
10
RSG
71
3
DTE
56
2
LMT
34
2
HSIC
56
5
MAS
58
2
MLM
57
6
AAP
24
6
PVH
62
5
HCP
66
8
WM
79
3
XYL
49
4
UNP
52
7
BK
74
2
WU
32
2
SLB
55
2
NDAQ
62
2
NWL
53
3
HPQ
63
6
KEY
46
3
VNO
60
10
RSG
71
3
DTE
56
2
LMT
34
2
HSIC
56
5
MAS
58
2
MLM
57
6
AAP
24
6
PVH
62
5
HCP
66
8
WM
79
3
XYL
49
4
UNP
52
7
BK
74
2
WU
32
2
SLB
55
2
NDAQ
62
2
Financhill
Back

Dianthus Therapeutics Vs. Cartesian Therapeutics Industry Stock Comparison

Sell
13

DNTH
Dianthus Therapeutics

Last Price:
22.35
Seasonality Move:
19.21%
Sell
40

RNAC
Cartesian Therapeutics

Last Price:
18.99
Seasonality Move:
13.13%
Sell
13
Dianthus Therapeutics (DNTH) is a Sell

Is Dianthus Therapeutics a Buy, Sell or Hold?

  • The current Dianthus Therapeutics [DNTH] share price is $22.34. The Score for DNTH is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
  • DNTH is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
40
Cartesian Therapeutics (RNAC) is a Sell

Is Cartesian Therapeutics a Buy, Sell or Hold?

  • The current Cartesian Therapeutics [RNAC] share price is $18.87. The Score for RNAC is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • RNAC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DNTH Stock Price Chart

What is Dianthus Therapeutics's stock price today?

  • The Dianthus Therapeutics share price today is $22.34
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DNTH is experiencing buying pressure, which is a positive indicator for future bullish movement.

RNAC Stock Price Chart

What is Cartesian Therapeutics's stock price today?

  • The Cartesian Therapeutics share price today is $18.87
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNAC is experiencing buying pressure, which is a positive indicator for future bullish movement.

DNTH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.66 Sell
Relative Strength Index (14 RSI): 35.51 Sell
Chaikin Money Flow: 269401 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (23.84 - 29.26) Sell
Bollinger Bands (100): (25.83 - 29.23) Sell

RNAC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.71 Sell
Relative Strength Index (14 RSI): 49.49 Sell
Chaikin Money Flow: 56766 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.74 - 21.66) Sell
Bollinger Bands (100): (14.35 - 20.33) Buy

DNTH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 23.06 Sell
20-day SMA: 26.25 Sell
50-day SMA: 26.97 Sell
200-day SMA: 26.18 Sell
8-day EMA: 23.05 Sell
20-day EMA: 25.16 Sell
50-day EMA: 26.52 Sell
200-day EMA: 24.89 Sell

RNAC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.5 Buy
20-day SMA: 19.15 Sell
50-day SMA: 19.39 Sell
200-day SMA: 19.98 Sell
8-day EMA: 17.91 Buy
20-day EMA: 18.75 Buy
50-day EMA: 18.93 Sell
200-day EMA: 20.95 Sell

Dianthus Therapeutics Earnings Growth & DNTH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Cartesian Therapeutics Earnings Growth & RNAC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.90 per share, and an increase next year of $1.70 per share.

Dianthus Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cartesian Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):